Literature DB >> 22284026

Are the results of RTOG 0617 mysterious?

James D Cox.   

Abstract

Mesh:

Year:  2012        PMID: 22284026     DOI: 10.1016/j.ijrobp.2011.12.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  45 in total

Review 1.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

Review 2.  Lessons learned from radiation oncology clinical trials.

Authors:  Fei-Fei Liu; Paul Okunieff; Eric J Bernhard; Helen B Stone; Stephen Yoo; C Norman Coleman; Bhadrasain Vikram; Martin Brown; John Buatti; Chandan Guha
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

3.  Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT.

Authors:  Jian He; Yan Huang; Yixing Chen; Shiming Shi; Luxi Ye; Yong Hu; Jianying Zhang; Zhaochong Zeng
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

4.  An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.

Authors:  Marie Wanet; Antoine Delor; François-Xavier Hanin; Benoît Ghaye; Aline Van Maanen; Vincent Remouchamps; Christian Clermont; Samuel Goossens; John Aldo Lee; Guillaume Janssens; Anne Bol; Xavier Geets
Journal:  Strahlenther Onkol       Date:  2017-07-21       Impact factor: 3.621

Review 5.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

6.  [Distribution of coronary artery stenosis after radiation for breast cancer].

Authors:  F Lohr; F Heggemann
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

Review 7.  Promise and pitfalls of heavy-particle therapy.

Authors:  Timur Mitin; Anthony L Zietman
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 8.  Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.

Authors:  Carri K Glide-Hurst; Indrin J Chetty
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

9.  Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer.

Authors:  George Rodrigues
Journal:  Transl Lung Cancer Res       Date:  2016-04

10.  The evolution of proton beam therapy: Current and future status.

Authors:  Xiufang Tian; Kun Liu; Yong Hou; Jian Cheng; Jiandong Zhang
Journal:  Mol Clin Oncol       Date:  2017-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.